Genprex (GNPX) Projected to Post Quarterly Earnings on Monday

Genprex (NASDAQ:GNPX) will likely be issuing its quarterly earnings data before the market opens on Monday, April 7th. Analysts expect the company to announce earnings of ($0.39) per share for the quarter.

Genprex Trading Down 22.4 %

Shares of Genprex stock opened at $0.34 on Friday. Genprex has a 52-week low of $0.22 and a 52-week high of $4.09. The company has a 50 day moving average of $0.41 and a 200 day moving average of $0.81.

About Genprex

Genprex, Inc, a clinical-stage gene therapy company, focuses on developing gene-based therapies for patients with cancer and diabetes in the United States. The company's lead product candidate is REQORSA (GPX-001), which is in preclinical trials to treat non-small cell lung cancer and small cell lung cancer; and GPX-002, which is in preclinical trials to treat type 1 and type 2 diabetes.